Prime Medicine, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -10.33 | -100% |
| P/S |
|
120.86 | 33.44 | 261.49% |
|
|
| P/BV |
|
6.29 | 4.64 | 35.45% |
|
|
| P/FCF |
|
-6.66 | 42.53 | -115.66% |
|
|
| Ev/Ebitda |
|
-4.33 | -17.68 | -75.48% |
|
|
| Ev/S |
|
155.57 | 22.59 | 588.54% |
|
|
| Ev/FCF |
|
-4.65 | 47.55 | -109.77% |
|
|
| E/P |
|
-0.1708 | 0.0182 | -1038.46% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-3589.21 | -14.2 | 25169.47% | -1485.17 | +141.67% |
| ROE |
|
-148.89 | 9.78 | -1622% |
|
|
| ROA |
|
-102.21 | 0.33 | -31067.82% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-3810.25 | -26.41 | 14325.26% |
|
|
| ROCE |
|
-143.75 | 14.5 | -1091.26% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.073 | -3.87 | -98.11% | -0.1201 | -39.19% |
| Nеt Debt/Ebitda |
|
0.1497 | -4.24 | -103.53% |
|
|
| Debt/Ratio |
|
0.0703 | 0.1853 | -62.05% |
|
|
| Debt/Equity |
|
0.7175 | 1.56 | -54.09% |
|
|
| Debt/Net Income |
|
-0.0688 | 10.06 | -100.68% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
0.1923 | 30.62 | -99.37% | ||
| Growth impulse Ebitda in 5 years |
|
8707.23 | -17.42 | -50084.1% | ||
| Growth impulse Net Income in 5 years |
|
7825.32 | -52.26 | -15073.82% | ||
| Growth impulse FCF in 5 years |
|
13295.08 | -31.68 | -42066.79% | ||
| Growth impulse EPS in 5 years |
|
8150.08 | -61.82 | -13283.57% |
IP Score
4.15/10
